Pelthos Therapeutics's total assets for Q1 2026 were $145.38M, an increase of 11.49% from the previous quarter. PTHS total liabilities were $110.28M for the fiscal quarter, a 20.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.